Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Journal article |
| Idioma: | English |
| Publicado: |
Elsevier
2007
|
| Subjects: |